| Literature DB >> 33656835 |
Kai-Peng Sun1,2,3, Ning Xu1,2,3, Shu-Ting Huang1,2,3, Hua Cao1,2, Qiang Chen1,2,3.
Abstract
INTRODUCTION: The objective of this study is to evaluate the efficacy and midterm prognosis of transcatheter device closure of atrial septal defects (ASDs) in sexagenary patients in China.Entities:
Keywords: Feedback; Follow-Up Studies; Health Surveys; Heart Septal Defects, Atrial; Prognosis; Quality of Life; Sexagenary
Mesh:
Year: 2022 PMID: 33656835 PMCID: PMC8973138 DOI: 10.21470/1678-9741-2020-0387
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Sociodemographic characteristics of the participants.
| Item | Mean±SD/N (%) |
|---|---|
| Mean age (years) | 64.8±3.7 |
| Gender | |
| Male | 14 (35%) |
| Female | 26 (65%) |
| Weight (kg) | 64.5±6.8 |
| Height (cm) | 162.3±5.6 |
| ASD size (mm) | 17.5±6.4 |
| ASD occluder (mm) | 22.4±10.6 |
| In-hospital stay (days) | 4.2±1.4 |
| Diabetes mellitus | 9 (22.5%) |
| Coronary heart disease | 4 (10%) |
| Hypertension | 12 (30%) |
| Dyslipidemia | 15 (37.5%) |
| Smoking | 10 (25%) |
ASD=atrial septal defect; SD=standard deviation
Fig. 1Number of patients with dyspnea or palpitations before and after atrial septal defect (ASD) device closure.
Changes of echocardiographic parameters after ASD closure.
| Item | Preoperatively | 3 months after ASD closure | 1 year after ASD closure |
|---|---|---|---|
| End-systolic length of RA (mm) | 56.8±8.4 | 45.7±5.9 | 44.9±6.7 |
| End-systolic width of RA (mm) | 49.5±7.9 | 37.6±8.3 | 36.8±7.3 |
| End-diastolic anteroposterior diameter of RV (mm) | 35.6±6.2 | 26.4±5.0 | 24.2±6.2 |
| End-diastolic length of RV (mm) | 72.0±10.5 | 62.2±11.2 | 61.4±11.7 |
| End-diastolic width of RV (mm) | 46.2±11.6 | 33.9±7.7 | 32.4±8.8 |
| Inner diameter of the middle portion of the pulmonary artery (mm) | 27.0±5.1 | 24.2±4.2 | 22.6±6.1 |
| End-systolic anteroposterior diameter of LA (mm) | 28.7±4.8 | 29.0±5.6 | 28.5±4.5 |
| End-systolic anteroposterior diameter of LV (mm) | 25.7±7.3 | 27.5±6.4 | 28.8±6.7 |
| End-diastolic anteroposterior diameter of LV (mm) | 41.2±5.0 | 45.8±6.2 | 46.3±5.8 |
| E/A | 1.4±0.3 | 1.3±0.4 | 1.3±0.2 |
| Left ventricular ejection fraction (%) | 61.3±5.8 | 60.5±6.7 | 59.5±6.2 |
ASD=atrial septal defect; E/A=peak of mitral flow spectrum; LA=left atrium; LV=left ventricle; RA=right atrium; RV=right ventricle
Significantly different from preoperative value (P<0.05)
Result of SF-36 scores before and after ASD closure.
| Before ASD closure | 3 months after ASD closure | 1 year after ASD closure | |||
|---|---|---|---|---|---|
| PF | 50.2±15.4 | 62.6±10.1 | 64.2±9 | ||
| RP | 43.5±23.1 | 57.3±19.1 | 59.6±15.7 | ||
| BP | 58.6±18.4 | 68.3±11.4 | 68.7±10 | ||
| GH | 53.1±17.9 | 64.3±11.4 | 63.8±8.8 | ||
| VT | 49.0±19.5 | 61.0±10.9 | 61.8±7.7 | ||
| SF | 53.0±17.2 | 66.5±10.8 | 66.9±8.5 | ||
| RE | 41.5±24.3 | 56.4±25 | 58.5±22.9 | ||
| MH | 59.3±15.7 | 71.4±8.3 | 72.1±6.1 |
ASD=atrial septal defect; BP=bodily pain; GH=general health; MH=mental health; PF=physical functioning; RE=role emotional; RP=role physical; SF=social functioning; SF-36=36-Item Short-Form Health Survey; VT=vitality
| Abbreviations, acronyms & symbols | ||||
|---|---|---|---|---|
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
| |||
| Authors' roles & responsibilities | |
|---|---|
| K-PS | Substantial contributions to the design of the work; analysis of data for the work; drafting the work; final approval of the version to be published |
| NX | Substantial contributions to the design of the work; analysis of data for the work; drafting the work |
| S-TH | Analysis of data for the work; final approval of the version to be published |
| HC | Acquisition of data for the work; final approval of the version to be published |
| QC | Substantial contributions to the design of the work; acquisition and analysis of data for the work; drafting the work; final approval of the version to be published |